Patents by Inventor Richard Hill

Richard Hill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9999984
    Abstract: A circular cutting blade is configured for cutting meat when turned about a rotation axis in a predetermined cutting direction. The cutting blade has a peripheral blade edge defined between the first and second sides and a plurality of circumferentially disposed cutting knives. Each cutting knife includes first and second knife sides and an arcuate knife edge that constitutes a portion of the peripheral blade edge. Each knife edge is titled and rises, relative to the rotation axis, between a first blade-edge location corresponding to a minor blade radius and a second blade-edge location corresponding to a major blade radius such that, when the circular blade is rotating in the predetermined cutting direction and cutting a work piece, the work piece first encounters the first blade-edge location of each cutting knife before encountering the second blade-edge location of that cutting knife.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: June 19, 2018
    Assignee: HYDE TOOLS, INC.
    Inventors: Eric C. Wilhelm, Richard M. Clemence, William Hill, Richard N. Cloutier
  • Publication number: 20180161205
    Abstract: Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye. The implant is implanted into eye tissue adjacent the anterior chamber such that a proximal end of the implant resides in the anterior chamber following implantation. A therapeutic agent is eluted from the implant into the eye. Desirably, the release of the therapeutic agent from the implant is controlled. The controlled release of the therapeutic agent can be at a chosen rate and/or for a selected duration which can be episodic or periodic. The therapeutic agent can be an antiproliferative agent, an anti-inflammatory drug, or a compound for treating glaucoma or ocular hypertension.
    Type: Application
    Filed: October 16, 2017
    Publication date: June 14, 2018
    Inventors: Hosheng Tu, Barbara A. Niksch, David S. Haffner, Gregory T. Smedley, Olav B. Bergheim, Morteza Gharib, Richard A. Hill, Thomas W. Burns
  • Patent number: 9993368
    Abstract: Surgical methods and related medical devices for treating ocular disorders are disclosed. Some methods relate to delivering an implant within an eye, and involve providing an elongate guide device, such as, a flexible guide member or a guide wire. A distal end of the guide device can be advanced into an anterior chamber of an eye, or through at least a portion of a site of resistance along a physiologic outflow pathway of the eye, or from an anterior chamber of the eye to a location proximate a physiologic outflow pathway of the eye. The implant is advanced along the guide device toward the guide device distal end, and is positioned to conduct aqueous humor between the anterior chamber and the physiologic outflow pathway.
    Type: Grant
    Filed: October 28, 2010
    Date of Patent: June 12, 2018
    Assignee: Glaukos Corporation
    Inventors: Olav B. Bergheim, Morteza Gharib, Richard A. Hill
  • Patent number: 9987472
    Abstract: Systems and methods for treating ocular disorders are disclosed. One system has a delivery instrument, with a non-linear axis, configured to be inserted into an anterior chamber of an eye and moved to a location proximate a physiologic outflow pathway of the eye. The delivery instrument carries an implant that has a distal end sized for insertion into tissue such that aqueous humor drains from the anterior chamber to the physiologic outflow pathway. One method involves inserting a non-linear portion of a delivery device into the anterior chamber to position an implant within the eye. Another method involves using a delivery device with a curved distal portion to implant an implant at a location communicating with the physiologic outflow pathway. The delivery can be through a corneal incision and the implant can comprise a drug.
    Type: Grant
    Filed: December 27, 2010
    Date of Patent: June 5, 2018
    Assignee: GLAUKOS CORPORATION
    Inventors: Hosheng Tu, Gregory T. Smedley, David Steven Haffner, Barbara A. Niksch, Richard A. Hill, Olav B. Bergheim
  • Patent number: 9984554
    Abstract: Methods and apparatuses are disclosed that allow an electronic device to autonomously adapt one or more user alerts to the current operating environment of the electronic device. For example, some embodiments may include a method comprising providing a plurality of alert devices in an electronic device, determining an operating environment of the electronic device using a sensor of the electronic device, and actuating at least one of the plurality of alert devices that corresponds to the determined operating environment.
    Type: Grant
    Filed: June 20, 2017
    Date of Patent: May 29, 2018
    Assignee: Apple Inc.
    Inventors: Dave Pakula, Matthew Hill, Ethan Larry Huwe, Fletcher R. Rothkopf, Richard Hung Minh Dinh
  • Patent number: 9962290
    Abstract: Devices and methods for treating intraocular pressure are disclosed. The devices include shunts for draining aqueous humor from the anterior chamber to the uveoscleral outflow pathway, including the supraciliary space and the suprachoroidal space. The shunts are preferably implanted by ab interno procedures.
    Type: Grant
    Filed: August 12, 2013
    Date of Patent: May 8, 2018
    Assignee: Glaukos Corporation
    Inventors: Thomas W. Burns, David Haffner, Harold A. Heitzmann, Todd N. Fjield, Richard A. Hill
  • Publication number: 20180117078
    Abstract: Compositions and methods are provided for enhancing the expression of human beta defensin 2 (HBD2) in human colon epithelium cells. The method comprises orally administering a composition comprising hyaluronan, where said hyaluronan has a molecular weight within the range of about 35 kDa.
    Type: Application
    Filed: October 31, 2017
    Publication date: May 3, 2018
    Inventors: Carol de la MOTTE, Sean KESSLER, David Richard HILL
  • Patent number: 9888265
    Abstract: There is provided a content automation system and a method for use by the content automation system for issuing a content management message for use in a program stream. In one implementation, such a content automation system comprises a processor and a memory, and a stream messaging module residing in the memory. The stream messaging module is configured to issue the content management message by embedding a command sequence as metadata in a container data structure, and inserting the container data structure into the program stream. The command sequence authorizes a replacement of program stream content.
    Type: Grant
    Filed: June 19, 2012
    Date of Patent: February 6, 2018
    Assignee: Disney Enterprises, Inc.
    Inventors: Michael Martin, Daniel Siewers, William Hooper, David Potter, Richard Hill, Michael Strein, Kenneth Michel, Alfredo Vincenty, James Casabella, David Converse, Guy Beverlin
  • Publication number: 20180027263
    Abstract: There is provided a content automation system and a method for use by the content automation system for issuing a content management message for use in a program stream. In one implementation, such a content automation system comprises a processor and a memory, and a stream messaging module residing in the memory. The stream messaging module is configured to issue the content management message by embedding a command sequence as metadata in a container data structure, and inserting the container data structure into the program stream. The command sequence authorizes a replacement of program stream content.
    Type: Application
    Filed: October 3, 2017
    Publication date: January 25, 2018
    Inventors: Michael Martin, Daniel Siewers, William Hooper, David Potter, Richard Hill, Michael Strein, Kenneth Michel, Alfredo Vincenty, James Casabella, David Converse, Guy Beverlin
  • Patent number: 9858729
    Abstract: A pipette check station for checking the calibration or service status of a pipette includes an RFID reader, a user interface with a display and buttons, and a digital interface to connect the check station to additional equipment; the check station optionally further includes provisions to hold pipettes for storage and to charge electronic pipettes held thereupon.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: January 2, 2018
    Assignee: Mettler-Toledo Rainin, LLC
    Inventors: Gerhard Keller, Richard Hill, Deryl Stanley, James Petrek, Murray Anderson
  • Publication number: 20170368024
    Abstract: Compositions and methods for treating glaucoma by restoring the filtration capabilities of the endothelial lining of Schlemm's canal are provided. More particularly, methods of lowering intraocular pressure are disclosed, where a subject in need of such treatment is administered a therapeutically effective amount of a composition. In various embodiments, the composition may include tyrosine or L-DOPA conjugated to an ascorbic acid, an enzyme, a nucleic acid encoding an enzyme, or trabecular meshwork cells.
    Type: Application
    Filed: December 28, 2015
    Publication date: December 28, 2017
    Inventor: Richard A. Hill
  • Patent number: 9789001
    Abstract: Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye. The implant is implanted into eye tissue adjacent the anterior chamber such that a proximal end of the implant resides in the anterior chamber following implantation. A therapeutic agent is eluted from the implant into the eye. Desirably, the release of the therapeutic agent from the implant is controlled. The controlled release of the therapeutic agent can be at a chosen rate and/or for a selected duration which can be episodic or periodic. The therapeutic agent can be an antiproliferative agent, an anti-inflammatory drug, or a compound for treating glaucoma or ocular hypertension.
    Type: Grant
    Filed: June 29, 2015
    Date of Patent: October 17, 2017
    Assignee: DOSE MEDICAL CORPORATION
    Inventors: Hosheng Tu, Barbara A. Niksch, David S. Haffner, Gregory T. Smedley, Olav B. Bergheim, Morteza Gharib, Richard A. Hill, Thomas W. Burns
  • Publication number: 20170246034
    Abstract: Drainage of body fluid from an area of undesirably high pressure can be accomplished by interconnecting an artificial non-blood fluid conduit with the vascular system. For example, an artificial non-blood fluid conduit can be inserted into the eye to fluidly interconnect the anterior chamber with a location of lower pressure. The conduit can have a growth factor for stimulating growth of new blood vessels in the location of lower pressure to connect the new blood vessels with the non-blood fluid conduit.
    Type: Application
    Filed: April 21, 2017
    Publication date: August 31, 2017
    Inventor: Richard A. HILL
  • Patent number: 9700724
    Abstract: An apparatus and method for electrical charge balancing when generating a stimulus during functional neural stimulation is presented. A stimulus pulse is generated (cathodic or anodic), and after a selected delay a charge compensating pulse is generated of an opposite polarity. The electrode circuit discontinuously examines electrode voltage after termination of the stimulus pulse, and utilizes this voltage to determine how long to extend the width of the charge compensating pulse. The electrode circuit thus performs accurate electrical charge cancellation to remove residual charges from the electrode by precisely controlling pulse width for an opposing polarity compensating pulse that need not have the same current level as the stimulus pulse.
    Type: Grant
    Filed: August 23, 2015
    Date of Patent: July 11, 2017
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Wentai Liu, Richard Hill, Yi-Kai Lo, Kuanfu Chen
  • Publication number: 20170193712
    Abstract: A pipette check station for checking the calibration or service status of a pipette includes an RFID reader, a user interface with a display and buttons, and a digital interface to connect the check station to additional equipment; the check station optionally further includes provisions to hold pipettes for storage and to charge electronic pipettes held thereupon.
    Type: Application
    Filed: December 31, 2015
    Publication date: July 6, 2017
    Inventors: Gerhard Keller, Richard Hill, Deryl Stanley, James Petrek, Murray Anderson
  • Patent number: 9655780
    Abstract: Drainage of body fluid from an area of undesirably high pressure can be accomplished by interconnecting an artificial non-blood fluid conduit with the vascular system. For example, an artificial non-blood fluid conduit can be inserted into the eye to fluidly interconnect the anterior chamber with a location of lower pressure. The conduit can have a growth factor for stimulating growth of new blood vessels in the location of lower pressure to connect the new blood vessels with the non-blood fluid conduit.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: May 23, 2017
    Assignee: Orange County Glaucoma, PC
    Inventor: Richard A. Hill
  • Publication number: 20170049967
    Abstract: Devices, systems and methods for needle free injection include a multi-use needle-free injection device comprising reversibly connected proximate and distal sections, wherein the proximate section comprises a power supply, actuator, circuitry and a housing, and the distal section comprises a disposable nozzle tip prefilled with an injectate, a chemical energetic device, and a dual seal piston barrier between the energetic device and the injectate, wherein the proximate and distal sections and their components are operably linked and configured for single-hand injecting of the injectate.
    Type: Application
    Filed: November 4, 2016
    Publication date: February 23, 2017
    Inventors: David Fouche, Michael Vestel, John P. Marlow, Mark A. Petrie, Robert A. Brown, Hilary Lackritz, Richard A. Hill, Donald English, Mark Nansen, Mark Hansen, Martin Martoza
  • Patent number: 9572963
    Abstract: An embodiment of a system for shunting aqueous humor from an anterior chamber of an eye includes an implant having an elongated body made of biocompatible material and a delivery device. At least a portion of the elongated body is implantable between a sclera and a ciliary body while the elongated body resides entirely within the confines of the sclera and a cornea with the proximal end of the implant being configured to reside within an anterior chamber angle and a lumen extending from at least one inlet port of the implant, through at least a portion of the elongated body, to one or more outlet ports of the implant so as to drain fluid from the anterior chamber toward a choroid of the eye. The delivery device includes an elongated member with a curved distal end portion to deliver the implant using an ab interno procedure.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: February 21, 2017
    Assignee: Glaukos Corporation
    Inventors: Hosheng Tu, Barbara A. Niksch, David Steven Haffner, Gregory T. Smedley, Richard A. Hill, Olav B. Bergheim
  • Publication number: 20160345608
    Abstract: An air-stable, high-melt 1a-hydroxy-vitamin D3 compound, methods for preparing an animal feed composition, methods of preparing 1?-hydroxy-vitamin D3, methods of enhancing phytate phosphorus and calcium utilization, and an animal feed regime are provided.
    Type: Application
    Filed: June 2, 2016
    Publication date: December 1, 2016
    Inventors: Hardy M. Edwards, III, George Majetich, Richard Hill, Dezhi Sha, George Yiannikouros
  • Patent number: D782055
    Type: Grant
    Filed: December 2, 2014
    Date of Patent: March 21, 2017
    Inventor: Martin Richard Hill